References

1. Paweletz, C.P.; Charboneau, L.; Bichsel, V.E.; Simone, N.L.; Chen, T.; Gillespie, J.W.; Emmert-Buck, M.R.; Roth, M.J.; Petricoin, I.E.; Liotta, L.A. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 2001, 20 (16), 1981-1989.

2. Zhu, H.; Snyder, M. Protein chip technology. Curr. Opin. Chem. Biol. 2003, 7 (1), 55-63.

3. MacBeath, G. Protein microarrays and proteomics. Nat. Genet. 2002, 32 (Suppl), 526-532.

4. MacBeath, G.; Schreiber, S.L. Printing proteins as micro-arrays for high-throughput function determination. Science 2000, 289 (5485), 1760-1763.

5. Haab, B.B.; Dunham, M.J.; Brown, P.O. Protein micro-arrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. 2001, 2 (2). RESEARCH0004.

6. Liotta, L.A.; Espina, V.; Mehta, A.I.; Calvert, V.; Rosenblatt, K.; Geho, D.; Munson, P.J.; Young, L.; Wulfkuhle, J.; Petricoin, E.F. Protein microarrays: Meeting analytical challenges for clinical applications. Cancer Cell. 2003, 3 (4), 317-325.

7. Weng, S.; Gu, K.; Hammond, P.W.; Lohse, P.; Rise, C.; Wagner, R.W.; Wright, M.C.; Kuimelis, R.G. Generating addressable protein microarrays with PROfusion covalent mRNA-protein fusion technology. Proteomics 2002, 2 (1), 48-57.

8. Schaeferling, M.; Schiller, S.; Paul, H.; Kruschina, M.; Pavlickova, P.; Meerkamp, M.; Giammasi, C.; Kambhampati, D. Application of self-assembly techniques in the design of biocompatible protein microarray surfaces. Electrophoresis 2002, 23 (18), 3097-3105.

9. Petach, H.; Gold, L. Dimensionality is the issue: Use of photoaptamers in protein microarrays. Curr. Opin. Bio-technol. 2002, 13, 309-314.

10. Humphery-Smith, I.; Wischerhoff, E.; Hashimoto, R. Protein arrays for assessment of target selectivity. Drug Discov. World 2002, 4 (1), 17-27.

11. Lal, S.P.; Christopherson, R.I.; dos Remedios, C.G. Antibody arrays: An embryonic but rapidly growing technology. Drug Discov. Today 2002, 7 (18 Suppl), S143-S149.

12. Templin, M.F.; Stoll, D.; Schrenk, M.; Traub, P.C.; Vohringer, C.F.; Joos, T.O. Protein microarray technology. Trends Biotechnol. 2002, 20 (4), 160-166.

13. Wilson, D.S.; Nock, S. Recent developments in protein microarray technology. Angew. Chem. Int. Ed. Engl. 2003, 42 (5), 494-500.

14. Petricoin, E.F.; Zoon, K.C.; Kohn, E.C.; Barrett, J.C.; Liotta, L.A. Clinical proteomics: Translating benchside promise into bedside reality. Nat. Rev. Drug Discov. 2002, 1 (9), 683-695.

15. Liotta, L.A.; Kohn, E.C.; Petricoin, E.F. Clinical proteomics: Personalized molecular medicine. JAMA 2001, 286 (18), 2211-2214.

16. Liotta, L.A.; Clair, T. Cancer. Checkpoint for invasion. Nature 2000, 405 (6784), 287-288.

17. Liotta, L.A.; Kohn, E.C. The microenvironment of the tumour-host interface. Nature 2001, 411 (6835), 375-379.

18. Liotta, L.A. An attractive force in metastasis. Nature 2001, 410 (6824), 24-25.

19. Hanahan, D.; Weinberg, R.A. The hallmarks of cancer. Cell 2000, 100 (1), 57-70.

20. Hunter, T. The Croonian lecture 1997. The phosphoryla-tion of proteins on tyrosine: Its role in cell growth and disease. Philos. Trans. R. Soc. Lond., B Biol. Sci. 1998, 353 (1368), 583-605.

21. Hunter, T. Signaling—2000 and beyond. Cell 2000, 100 (1), 113-127.

22. Bowden, E.T.; Barth, M.; Thomas, D.; Glazer, R.I.; Mueller, S.C. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene 1999, 18 (31), 4440-4449.

23. Blume-Jensen, P.; Hunter, T. Oncogenic kinase signalling. Nature 2001, 411 (6835), 355-3265.

24. Celis, J.E.; Gromov, P. Proteomics in translational cancer research: Toward an integrated approach. Cancer Cell. 2003, 3 (1), 9-15.

25. Jeong, H.; Tombor, B.; Albert, R.; Oltvai, Z.N.; Barabasi, A.L. The large-scale organization of metabolic networks. Nature 2000, 407 (6804), 651-654.

26. Oltvai, Z.N.; Barabasi, A.L. Systems biology. Life's complexity pyramid. Science 2002, 298 (5594), 763-764.

27. Charboneau, L. Utility of reverse phase protein arrays: Applications to signaling pathways and human body arrays. Brief. Funct. Genomics Proteomics 2002, 1 (3), 305-315.

28. Knezevic, V.; Leethanakul, C.; Bichsel, V.E.; Worth, J.M.; Prabhu, V.V.; Gutkind, J.S.; Liotta, L.A.; Munson, P.J.; Petricoin, E.F., 3rd; Krizman, D.B. Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics 2001, 1 (10), 1271-1278.

29. Emmert-Buck, M.R.; Bonner, R.F.; Smith, P.D.; Chuaqui, R.F.; Zhuang, Z.; Goldstein, S.R.; Weiss, R.A.; Liotta, L.A. Laser capture microdissection. Science 1996, 274 (5289), 998-1001.

30. Emmert-Buck, M.R.; Strausberg, R.L.; Krizman, D.B.; Bonaldo, M.F.; Bonner, R.F.; Bostwick, D.G.; Brown, M.R.; Buetow, K.H.; Chuaqui, R.F.; Cole, K.A.; Duray, P.H.; Englert, C.R.; Gillespie, J.W.; Greenhut, S.; Grouse, L.; Hillier, L.W.; Katz, K.S.; Klausner, R.D.; Kuznetzov, V.; Lash, A.E.; Lennon, G.; Linehan, W.M.; Liotta, L.A.;

Marra, M.A.; Munson, P.J.; Ornstein, D.K.; Prabhu, V.V.; Prang, C.; Schuler, G.D.; Soares, M.B.; Tolstoshev, C.M.; Vocke, C.D.; Waterston, R.H. Molecular profiling of clinical tissues specimens: Feasibility and applications. J. Mol. Diagn. 2000, 2 (2), 60-66.

31. Nashat, A.H.; Moronne, M.; Ferrari, M. Detection of functional groups and antibodies on microfabricated surfaces by confocal microscopy. Biotechnol. Bioeng. 1998, 60 (2), 137-146.

32. Stillman, B.A.; Tonkinson, J.L. FAST slides: A novel surface for microarrays. Biotechniques 2000,29 (3), 630-635.

33. Tonkinson, J.L.; Stillman, B.A. Nitrocellulose: A tried and true polymer finds utility as a post-genomic substrate. Front Biosci. 2002, 7, c1-c12.

34. Schena, M. Microarray Biochip Technology; Eaton Pub: Natick, MA, 2000. xiv, 298, 32 of plates.

35. King, G.; Payne, S.; Walker, F.; Murray, G.I. A highly sensitive detection method for immunohistochemistry using biotinylated tyramine. J. Pathol. 1997, 183 (2), 237-341.

36. Kukar, T.; Eckenrode, S.; Gu, Y.; Lian, W.; Megginson, M.; She, J.X.; Wu, D. Protein microarrays to detect protein-protein interactions using red and green fluorescent proteins. Anal. Biochem. 2002, 306 (1), 50-54.

37. Morozov, V.N.; Gavryushkin, A.V.; Deev, A.A. Direct detection of isotopically labeled metabolites bound to a protein microarray using a charge-coupled device. J. Biochem. Biophys. Methods 2002, 51 (1), 57-67.

38. Schweitzer, B.; Roberts, S.; Grimwade, B.; Shao, W.; Wang, M.; Fu, Q.; Shu, Q.; Laroche, I.; Zhou, Z.; Tchernev, V.T.; Christiansen, J.; Velleca, M.; Kingsmore, S.F. Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat. Biotechnol. 2002, 20 (4), 359-365.

39. Wiese, R. Analysis of several fluorescent detector molecules for protein microarray use. Luminescence 2003, 18 (1), 25-30.

40. Bobrow, M.N.; Harris, T.D.; Shaughnessy, K.J.; Litt, G.J. Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J. Immunol. Methods 1989, 125 (1-2), 279 -285.

41. Bobrow, M.N.; Shaughnessy, K.J.; Litt, G.J. Catalyzed reporter deposition, a novel method of signal amplification. II. Application to membrane immunoassays. J. Immunol. Methods 1991, 137 (1), 103-112.

42. Graf, R.; Friedl, P. Detection of immobilized proteins on nitrocellulose membranes using a biotinylation-dependent system. Anal. Biochem. 1999, 273 (2), 291-297.

43. Hunyady, B.; Krempels, K.; Harta, G.; Mezey, E. Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immu-nostaining. J. Histochem. Cytochem. 1996, 44 (12), 13531362.

44. Espina, V.; Mehta, A.I.; Winters, M.E.; Calvert, V.; Wulfkuhle, J.; Petricoin, E.F., 3rd; Liotta, L.A. Protein microarrays: Molecular profiling technologies for clinical specimens. Proteomics 2003, 3 (11), 2091-2100.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment